Please login to the form below

Not currently logged in
Email:
Password:

Teva promotes Allan Oberman to take over from William Marth

Executive leadership changes also see Jill DeSimone join

Teva Allan ObermanTeva has made a number of changes to its executive leadership team, promoting Allan Oberman and appointing Jill DeSimone.

Oberman will oversee the Israel-based generics company's Americas business, taking over the role held by William Marth, who is stepping down as president and CEO of Teva Americas Generics.

Oberman was previously senior vice president of North America generic pharmaceuticals, and prior to that held a number of senior roles at the company since joining in 2000. He has also served as president of EMIA (Eastern Europe, Middle East, Israel and Africa), chief operating officer of the Teva International Group, and president and CEO of Teva Canada.

Meanwhile, Jill DeSimone joins Teva as senior vice president and general manager of Teva Global Women's Health, a newly-created post where she will oversee all aspects of the company's women's health franchise.

She comes to the company from Bristol-Myers Squibb, where she held various global leadership positions, most recently as senior vice president, US commercialisation excellence.

“These changes are part of our ongoing process to build a premier leadership team and reshape Teva,” said Dr Jeremy Levin, president and CEO of Teva. “Allan brings extensive experience in global generics to the company's Americas teams. Jill brings a great track record and many years of experience in building franchises in specialty medicine. 

The changes also see William Marth step down as president and CEO of Teva Americas with immediate effect and retire at the end of 2013, in the interim serving as a senior advisor to Teva's president and CEO Dr Jeremy Levin.

8th November 2012

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...
Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening...
Meeting1
Reimagining strategy development for a hybrid workforce
By Janice MacLennan...